학술논문
Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy
Document Type
Article
Author
Source
In: Molecular Therapy Nucleic Acids . (Molecular Therapy Nucleic Acids, 8 March 2022, 27:1179-1190)
Subject
Language
English
ISSN
21622531